8
Total investments
4
Early stage
2
Mid stage
0
Late stage
11y
Years active
Portfolio
8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2023
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.
We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.
Seed Investor
Mar 2021
K2bio is a Preclinical Contract Research Organization (CRO) located in Houston Texas. We provide full support for in vivo and in vitro demands and regulatory oversight for pharmaceutical products. Our team will provide customized solutions to ensure the most meaningful and accurate data is provided.
Seed Investor
Apr 2020
Terret is the leading provider of AI Revenue Agents for sales, account management, and CS teams. Terret’s Virtual Revenue Fleet drives productivity across the full revenue cycle. From generating forecasts and automating the sales process to researching accounts and building mutual action plans, leading companies rely on Terret to grow revenue while reducing GTM expenses.
Investor
Mar 2020
The better way to build your frontend. Convert Figma designs into clean, extendable React code, automatically. Build and iterate on your products faster than ever.
Seed Investor
Oct 2019
Strata is the go-to platform for Identity Orchestration, enabling enterprises to connect any app to any identity service—without the chaos of hard-wiring identity or rewriting applications. The company’s founders created the IDQL (Identity Query Language) standard and Hexa open-source software for multi-cloud policy orchestration and are co-authors of the SAML standard for SSO federation.
See how Strata can reduce IAM tech debt, improve security, break vendor lock-in, and minimize code maintenance for your enterprise apps. Use Identity Orchestration to easily migrate IDPs, integrate MFA or passwordless features on non-standard apps, and ensure continuous identity availability.
Investor
Jun 2018
Greensparc is a San Francisco-based sustainable computing start-up providing renewable energy-powered edge computing resources and real-time ESG data analytics. Greensparc aims to become the leading provider of sustainable edge computing resources and optimization strategies.
Seed Investor/Advisor
Nov 2015
InSync is a product of InSync.AI Inc. (formerly known as ShopInSync Inc), that offers a platform that enables brands and retailers to develop deep, contextual, human-like Chat assistants that work across platforms and applications. Our goal is to help our partners provide their customers with the superior customer experience and drive higher conversions, using our technologies that comprise of Natural Language Processing, Machine Learning, Context Management, Bot Engine, Deep Search etc.
Experience · 9 entries
All (9)
Investments (8)
2023
Investor
Mar 2023
ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.
We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.
2021
Seed Investor
Mar 2021
K2bio is a Preclinical Contract Research Organization (CRO) located in Houston Texas. We provide full support for in vivo and in vitro demands and regulatory oversight for pharmaceutical products. Our team will provide customized solutions to ensure the most meaningful and accurate data is provided.
2020
Seed Investor
Apr 2020
Terret is the leading provider of AI Revenue Agents for sales, account management, and CS teams. Terret’s Virtual Revenue Fleet drives productivity across the full revenue cycle. From generating forecasts and automating the sales process to researching accounts and building mutual action plans, leading companies rely on Terret to grow revenue while reducing GTM expenses.
Investor
Mar 2020
The better way to build your frontend. Convert Figma designs into clean, extendable React code, automatically. Build and iterate on your products faster than ever.
Show all 9 entries ↓
Investment activity
2015–2023 · 8 investments
Recent (last 2 years)Earlier
